| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/23/2011 | CN1751706B Method for extraction of red-rooted salvia |
| 03/23/2011 | CN1745768B Use of medicine containing Milkvetch Root against aspirin |
| 03/23/2011 | CN101990544A Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions |
| 03/23/2011 | CN101990428A Pharmaceutical formulation |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/23/2011 | CN101987833A Novel nilvaldipine crystal types and preparation method thereof |
| 03/23/2011 | CN101987200A Compound medicine containing antihypertensive peptide and aldosterone receptor antagonist for curing hypertension |
| 03/23/2011 | CN101987173A Traditional Chinese medicine for treating diabetic oculopathy |
| 03/23/2011 | CN101987169A Composition comprising an extract of herbal combination thereof for preventing and treating diabetes mellitus |
| 03/23/2011 | CN101987134A Traditional Chinese medicine for treating diabetic retinopathy |
| 03/23/2011 | CN101987130A Traditional Chinese medicine compound preparation for treating early hypertension kidney damage |
| 03/23/2011 | CN101987112A Medicine composition for treating cardio-cerebrovascular diseases and preparation method thereof |
| 03/23/2011 | CN101987098A Valsartan amlodipine medicine composition |
| 03/23/2011 | CN101744822B Medicinal composition for treating hemorrhoids |
| 03/23/2011 | CN101632773B Chinese medicinal composition for treating haemorrhoids and preparation method thereof |
| 03/23/2011 | CN101569689B Medicine for preventing and treating flurouracil phlebitis |
| 03/23/2011 | CN101543481B Double-layer breviscapine sustained-release tablet and preparation method thereof |
| 03/23/2011 | CN101507765B Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof |
| 03/23/2011 | CN101485640B Huperzine A mono-layer osmotic pump controlled release tablets |
| 03/23/2011 | CN101417057B Traditional Chinese medicine decoction for treating rheumatic heart disease |
| 03/23/2011 | CN101328221B Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 03/23/2011 | CN101313873B Biology polypeptide medicament blood vessel bracket and preparation method thereof |
| 03/23/2011 | CN101307043B 6,8-dimethylol chrysin and 6,8-dimethylol ether chrysin, method for preparing same and pharmaceutical use |
| 03/23/2011 | CN101297827B Medicament for curing coronary disease and coronary artery coating bracket coated therewith |
| 03/23/2011 | CN101274000B Medicine use of herb aralia elata seem |
| 03/23/2011 | CN101264132B Application of compound red sage root tablet in preparing medicine for treating aspirin resistance cardiovascular disease |
| 03/23/2011 | CN101234137B Drug for curing coronary disease |
| 03/23/2011 | CN101229221B Chinese traditional medicine for treating thromboangiitis obliterans and preparing method thereof |
| 03/23/2011 | CN101199660B Capsule dose for treating pile class sausage disease and preparing method thereof |
| 03/23/2011 | CN101152149B Trigone-leaf dioscorea opposita saponin liposome, method for preparing the same and use of the same |
| 03/23/2011 | CN101129394B New use of aesculin in preventing and/or treating cardiovascular disease |
| 03/23/2011 | CN101091747B Preparation method of forsythia fruit and effective part, and new message |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910626 Use of S1P receptor agonists in heart diseases |
| 03/22/2011 | US7910545 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 03/22/2011 | CA2639349C Derivatives of 1,2,4,5-tetrahydro-3h-benzazepines, their preparation and pharmaceutical compositions containing them |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2490531C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2473885C Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias |
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2460036C Medical devices containing rapamycin analogs |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2449215C (pyrido/thieno)-[f]-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 03/22/2011 | CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/22/2011 | CA2427072C N-alkylglycine trimers capable of protecting neurons against excitotoxic aggressions and compositions containing said trimers |
| 03/17/2011 | WO2011032099A1 Methods of treating diastolic dysfunction and related conditions |
| 03/17/2011 | WO2011031111A2 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 03/17/2011 | WO2011030892A1 Novel substrate peptide for rho-kinase |
| 03/17/2011 | WO2011030873A1 Benzyl compounds |
| 03/17/2011 | WO2011030868A1 Substituted carbonyl compounds |
| 03/17/2011 | WO2011030865A1 Substituted zenzyl compounds |
| 03/17/2011 | WO2011029861A1 Plgf-1 in homodimeric form |
| 03/17/2011 | WO2011029808A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/17/2011 | WO2011029359A1 MEDICAMENTS CONTAINING 11β HYDROXYSTEROID DEHYDROGENASE 1 DOUBLE REGULATORS AND USES THEREOF |
| 03/17/2011 | WO2010132347A9 Docosahexaenoic acid for the treatment of heart failure |
| 03/17/2011 | WO2010129670A3 Method for modulating angiogenesis using fibromodulin |
| 03/17/2011 | WO2010111215A4 Compositions and methods for treatment of hemorrhage |
| 03/17/2011 | WO2008102208A3 Inhibition of platelet aggregation |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110066230 Fluorinated GHRH Antagonists |
| 03/17/2011 | US20110065918 New phenylalanine derivatives |
| 03/17/2011 | US20110065796 Prodrugs of guanfacine |
| 03/17/2011 | US20110065793 Highly purified ethyl epa and other epa derivatives |
| 03/17/2011 | US20110065783 Hydroxylated nebivolol metabolites |
| 03/17/2011 | US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 03/17/2011 | US20110065769 Transdermal delivery of ionizable drugs |
| 03/17/2011 | US20110065765 Angiotensin ii receptor antagonists |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065759 5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide and salts thereof |
| 03/17/2011 | US20110065758 Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions |
| 03/17/2011 | US20110065757 Methods for treatment of kallikrein-related disorders |
| 03/17/2011 | US20110065756 Methods and compositions for treatment of obesity-related diseases |
| 03/17/2011 | US20110065748 Compositions and methods for treating disorders of gastrointestinal motility |
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands |
| 03/17/2011 | US20110065738 Polycyclic guanine derivatives and use thereof |
| 03/17/2011 | US20110065736 Quinazoline derivatives as vegf inhibitors |
| 03/17/2011 | US20110065731 Uses of dpp-iv inhibitors |
| 03/17/2011 | US20110065716 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/17/2011 | US20110065712 Tricyclic compounds and pharmaceutical uses thereof |
| 03/17/2011 | US20110065703 Novel agents of calcium ion channel modulators |
| 03/17/2011 | US20110065697 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 03/17/2011 | US20110065685 Novel indoles are cannabinoid receptor ligands |
| 03/17/2011 | US20110065684 Phthalazine derivatives as parp inhibitors |
| 03/17/2011 | US20110065676 Combination therapies comprising par1 antagonists with nar agonists |
| 03/17/2011 | US20110065675 Azo dye related small molecule modulators of protein-protein interactions |
| 03/17/2011 | US20110065673 Novel leukotriene receptor agonist |
| 03/17/2011 | US20110065671 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 03/17/2011 | US20110065659 Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 03/17/2011 | US20110065644 Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use |
| 03/17/2011 | US20110065643 Clusterin Pharmaceuticals and Treatment Methods Using the Same |
| 03/17/2011 | US20110065641 Polypeptide and dna thereof useful as a neovascular marker |
| 03/17/2011 | US20110065640 Anti-invasive and anti-angiogenic compositions |
| 03/17/2011 | US20110065630 Use of a octreotide as a therapeutic agent |
| 03/17/2011 | US20110065179 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 03/17/2011 | US20110065147 Methods and reagents for modulating cholesterol levels |